FrancophonIA/ELRC3.0 huggingface dataset:
English: Renal and hepatic impairment
Croatian: Valproat i srodne tvari
English: Renal and urinary disorders:
Croatian: Poremećaji bubrega i mokraćnog sustava:
English: It is important that you continue to take Irbesartan Zentiva until your doctor tells you otherwise.
Croatian: Važno je da nastavite uzimati Irbesartan Zentiva sve dok Vam liječnik ne kaže drukčije.
English: Date of latest renewal: 19 January 2012
Croatian: Datum posljednje obnove: 19. siječnja 2012.
English: Irbesartan Zentiva should not be given to children under 18 years of age.
Croatian: Irbesartan Zentiva se ne smije davati djeci mlađoj od 18 godina.
English: See also information under the heading “Do not take Irbesartan Zentiva”.
Croatian: Vidjeti također informacije pod naslovom „Nemojte uzimati Irbesartan Zentiva“.
English: The safety and efficacy of Irbesartan Zentiva in children aged 0 to 18 has not been established.
Croatian: Sigurnost i djelotvornost lijeka Irbesartan Zentiva u djece u dobi od 0 do 18 godina nisu ustanovljene.
English: If you get any of these symptoms or get short of breath, stop taking Irbesartan Zentiva and contact your doctor immediately.
Croatian: Ako primijetite bilo koji od ovih simptoma ili osjetite nedostatak zraka, prestanite uzimati Irbesartan Zentiva i odmah se javite liječniku.
English: Irbesartan Zentiva with food and drink Irbesartan Zentiva can be taken with or without food.
Croatian: Irbesartan Zentiva s hranom i pićem Irbesartan Zentiva se može uzeti s hranom ili bez nje.
English: What Irbesartan Zentiva is and what it is used for What you need to know before you take Irbesartan Zentiva How to take Irbesartan Zentiva Possible side effects
Croatian: Što je Irbesartan Zentiva i za što se koristi Što morate znati prije nego počnete uzimati Irbesartan Zentiva Kako uzimati Irbesartan Zentiva Moguće nuspojave
English: What Irbesartan Zentiva is and what it is used for
Croatian: Što je Irbesartan Zentiva i za što se koristi
English: Your doctor will normally advise you to stop taking Irbesartan Zentiva before you become pregnant or as soon as you know you are pregnant and will advise you to take another medicine instead of Irbesartan Zentiva.
Croatian: Vaš će Vam liječnik obično preporučiti da prestanete uzimati Irbesartan Zentiva prije nego što zatrudnite ili čim saznate da ste trudni te će Vam savjetovati da uzmete neki drugi lijek umjesto lijeka Irbesartan Zentiva.
English: IDNT was a double blind, controlled, morbidity and mortality trial comparing Irbesartan Zentiva, amlodipine and placebo.
Croatian: IDNT je bilo dvostruko slijepo, kontrolirano ispitivanje morbiditeta i mortaliteta u kojem su uspoređivani Irbesartan Zentiva, amlodipin i placebo.
English: Other medicines and Irbesartan Zentiva
Croatian: Drugi lijekovi i Irbesartan Zentiva
English: Lactose: patients with rare hereditary problems of galactose intolerance, total lactase deficiency or glucose-galactose malabsorption should not take this medicine.
Croatian: Laktoza: bolesnici s rijetkim nasljednim poremećajem nepodnošenja galaktoze, potpunim nedostatkom laktaze ili malapsorpcijom glukoze i galaktoze ne bi smjeli uzimati ovaj lijek.
English: Irbesartan significantly reduced the relative risk in the primary combined endpoint of doubling serum creatinine, end-stage renal disease (ESRD) or all-cause mortality.
Croatian: Irbesartan značajno snižava relativni rizik u primarnoj kombiniranoj mjeri ishoda udvostručavanja serumskog kreatinina, terminalne faze bubrežne bolesti ili svih uzroka mortaliteta.
English: Please see section 2 “Irbesartan Zentiva contains lactose”.
Croatian: Vidjeti dio 2., „Irbesartan Zentiva sadrži laktozu“
English: What you need to know before you take Irbesartan Zentiva
Croatian: Što morate znati prije nego počnete uzimati Irbesartan Zentiva
English: No specific information is available on the treatment of overdose with Irbesartan Zentiva.
Croatian: Nema dostupnih specifičnih podataka o liječenju predoziranja lijekom Irbesartan Zentiva.
English: You can take Irbesartan Zentiva with or without food.
Croatian: Irbesartan Zentiva se može uzimati s hranom ili bez nje.
English: Irbesartan Zentiva is not recommended for mothers who are breast-feeding, and your doctor may choose another treatment for you if you wish to breast-feed, especially if your baby is newborn, or was born prematurely.
Croatian: Irbesartan Zentiva se ne preporučuje majkama koje doje, a Vaš liječnik može izabrati drugu terapiju ako želite dojiti, osobito ako se radi o dojenju novorođenčeta ili nedonoščeta.
English: While this is not documented with Irbesartan Zentiva, a similar effect should be anticipated with angiotensin-II receptor antagonists.
Croatian: Iako to još nije potvrđeno za Irbesartan Zentiva, sličan učinak može se očekivati s antagonistima receptora angiotenzina II.
English: Irbesartan Zentiva is unlikely to affect your ability to drive or use machines.
Croatian: Irbesartan Zentiva ne bi trebao utjecati na Vašu sposobnost upravljanja vozilima i strojevima.
English: There is no experience regarding the administration of Irbesartan Zentiva in patients with a recent kidney transplantation.
Croatian: Nema iskustava s primjenom lijeka Irbesartan Zentiva u bolesnika kojima je nedavno transplantiran bubreg.
English: Irbesartan Zentiva is indicated in adults for the treatment of essential hypertension.
Croatian: Irbesartan Zentiva je indiciran za liječenje esencijalne hipertenzije u odraslih.
English: Do not use this medicine after the expiry date which is stated on the carton and on the blister after EXP.
Croatian: Ovaj lijek se ne smije upotrijebiti nakon isteka roka valjanosti navedenog na kutiji i blisteru iza oznake „EXP“.
English: Regression to normoalbuminuria (< 30 mg/day) was more frequent in the Irbesartan Zentiva 300 mg group (34%) than in the placebo group (21%).
Croatian: Regresija do normoalbuminurije (< 30 mg/dan) bila je češća u skupini koja je primala lijek Irbesartan Zentiva u dozi od 300 mg (34%) nego u skupini koja je primala placebo (21%).
English: The blood pressure lowering effect of Irbesartan Zentiva is evident within 1-2 weeks, with the maximal effect occurring by 4-6 weeks after start of therapy.
Croatian: Učinak lijeka Irbesartan Zentiva na snižavanje krvnog tlaka vidljiv je unutar 1-2 tjedna, s maksimalnim učinkom nakon 4-6 tjedana od početka terapije.
English: Because no information is available regarding the use of Irbesartan Zentiva during breast-feeding, Irbesartan Zentiva is not recommended and alternative treatments with better established safety profiles during breast-feeding are preferable, especially while nursing a newborn or preterm infant.
Croatian: Budući da nema dostupnih podataka o upotrebi lijeka Irbesartan Zentiva tijekom dojenja, ne preporučuje se njegova primjena tijekom dojenja i prednost treba dati drugoj terapiji s ustanovljenim boljim profilom sigurnosti primjene, osobito kada se doji novorođenče ili nedonošče.
English: Prior treatment with high dose diuretics may result in volume depletion and a risk of hypotension when initiating therapy with Irbesartan Zentiva (see section 4.4).
Croatian: Prethodno liječenje visokim dozama diuretika može dovesti do smanjenja volumena i rizika od pojave hipotenzije prilikom uvođenja terapije lijekom Irbesartan Zentiva (vidjeti dio 4.4).
English: Irbesartan Zentiva belongs to a group of medicines known as angiotensin-II receptor antagonists.
Croatian: Irbesartan Zentiva pripada skupini lijekova koja se naziva antagonisti receptora angiotenzina II.
English: Irbesartan Zentiva is not recommended in early pregnancy, and must not be taken when more than 3 months pregnant, as it may cause serious harm to your baby if used after the third month of pregnancy.
Croatian: Irbesartan Zentiva se ne preporučuje u ranoj trudnoći te se ne smije uzimati nakon trećeg mjeseca trudnoće jer može ozbiljno naškoditi Vašem djetetu ako ga uzimate u tom razdoblju.
English: Such conditions should be corrected before the administration of Irbesartan Zentiva.
Croatian: Takva stanja treba korigirati prije primjene lijeka Irbesartan Zentiva.
English: Patients were titrated from 75 mg to a maintenance dose of 300 mg Irbesartan Zentiva, from 2.5 mg to 10 mg amlodipine, or placebo as tolerated.
Croatian: Bolesnici su titrirani od 75 mg do doze održavanja od 300 mg lijeka Irbesartan Zentiva, od 2,5 mg do 10 mg amlodipina ili placeba do granice podnošljivosti.
English: Irbesartan Zentiva at a dose of 150 mg once daily generally provides a better 24 hour blood pressure control than 75 mg.
Croatian: Doza od 150 mg lijeka Irbesartan Zentiva jedanput na dan općenito osigurava bolju kontrolu krvnog tlaka u razdoblju od 24 sata nego doza od 75 mg.
English: Renal impairment and kidney transplantation: when Irbesartan Zentiva is used in patients with impaired renal function, a periodic monitoring of potassium and creatinine serum levels is recommended.
Croatian: Oštećena funkcija bubrega i transplantacija bubrega: kad Irbesartan Zentiva uzimaju bolesnici s oštećenom funkcijom bubrega, preporučuje se periodički kontrolirati serumske razine kalija i kreatinina.
English: In particular, the addition of a diuretic such as hydrochlorothiazide has been shown to have an additive effect with Irbesartan Zentiva (see section 4.5).
Croatian: Pokazalo se da dodavanje diuretika poput hidroklorotiazida ostvaruje aditivan učinak s lijekom Irbesartan Zentiva (vidjeti dio 4.5).
English: If you forget to take Irbesartan Zentiva
Croatian: Ako ste zaboravili uzeti Irbesartan Zentiva
English: Date of first authorisation: 19 January 2007 Date of latest renewal: 19 January 2012
Croatian: Datum prvog odobrenja: 19. siječnja 2007.
English: Therefore, the use of Irbesartan Zentiva is not recommended.
Croatian: Stoga se ne preporučuje primjena lijeka Irbesartan Zentiva.
English: Undesirable effects where the frequency is not known are: feeling of spinning, headache, taste disturbance, ringing in the ears, muscle cramps, pain in joints and muscles, reduced number of platelets, abnormal liver function, increased blood potassium levels, impaired kidney function, inflammation of small blood vessels mainly affecting the skin (a condition known as leukocytoclastic vasculitis) and severe allergic reactions (anaphylactic shock).
Croatian: Nuspojave čija učestalost nije poznata su: vrtoglavica, glavobolja, poremećaji okusa, zvonjenje u ušima, grčevi u mišićima, bol u zglobovima i mišićima, smanjen broj krvnih pločica, poremećaj funkcije jetre, povišena razina kalija u krvi, oslabljena funkcija bubrega, upala malih krvnih žila koja uglavnom zahvaća kožu (stanje poznato kao leukocitoklastični vaskulitis) i teške alergijske reakcije (anafilaktički šok).
English: Irbesartan Zentiva prevents the binding of angiotensin-II to these receptors, causing the blood vessels to relax and the blood pressure to lower.
Croatian: Irbesartan Zentiva sprječava vezanje angiotenzina II na te receptore uzrokujući opuštanje krvnih žila i sniženje krvnog tlaka.
English: Lithium: the combination of lithium and Irbesartan Zentiva is not recommended (see section 4.5).
Croatian: Litij: ne preporučuje se kombinacija litija i lijeka Irbesartan Zentiva (vidjeti dio 4.5).
English: Hyperkalaemia: as with other medicinal products that affect the renin-angiotensin-aldosterone system, hyperkalaemia may occur during the treatment with Irbesartan Zentiva, especially in the presence of renal impairment, overt proteinuria due to diabetic renal disease, and/or heart failure.
Croatian: Hiperkalijemija: kao i kod ostalih lijekova koji djeluju na renin-angiotenzin-aldosteronski sustav, tijekom liječenja lijekom Irbesartan Zentiva može se pojaviti hiperkalijemija, posebice ako je prisutna oštećena bubrežna funkcija, izražena proteinurija zbog dijabetičke bubrežne bolesti i/ili zatajenje srca.
English: Irbesartan Zentiva is used in adult patients to treat high blood pressure (essential hypertension) to protect the kidney in patients with high blood pressure, type 2 diabetes and laboratory evidence of impaired kidney function.
Croatian: Irbesartan Zentiva se primjenjuje u odraslih bolesnika za liječenje visokog krvnog tlaka (esencijalne hipertenzije) zaštitu bubrega u bolesnika sa šećernom bolešću tipa 2 koji imaju povišeni krvni tlak i laboratorijski dokazanu oslabljenu bubrežnu funkciju.
English: Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system listed in Appendix V.
Croatian: Od zdravstvenih radnika se traži da prijave svaku sumnju na nuspojavu lijeka putem nacionalnog sustava prijave nuspojava: navedenog u u Dodatku V.
English: In 1,715 hypertensive patients with type 2 diabetes, proteinuria ≥ 900 mg/day and serum creatinine ranging from 1.0-3.0 mg/dl, the long-term effects (mean 2.6 years) of Irbesartan Zentiva on the progression of renal disease and all-cause mortality were examined.
Croatian: U 1715 hipertenzivnih bolesnika sa šećernom bolešću tipa 2, proteinurijom ≥ 900 mg/dan i serumskim kreatininom u rasponu od 1,0 do 3,0 mg/dl ispitivan je dugotrajan učinak lijeka Irbesartan Zentiva (prosječno 2,6 godina) na progresiju bubrežne bolesti i svih uzroka mortaliteta.
English: How to take Irbesartan Zentiva
Croatian: Kako uzimati Irbesartan Zentiva
English: The study examined the long-term effects (2 years) of Irbesartan Zentiva on the progression to clinical (overt) proteinuria (urinary albumin excretion rate (UAER) > 300 mg/day, and an increase in UAER of at least 30% from baseline).
Croatian: U ispitivanju su ispitivani dugotrajni učinci (2 godine) lijeka Irbesartan Zentiva na progresiju klinički izražene proteinurije (brzina izlučivanja albumina u mokraću > 300 mg/dan i porast u vrijednostima brzine izlučivanja albumina u mokraću od najmanje 30% u odnosu na početne vrijednosti).
English: Irbesartan Zentiva contains lactose.
Croatian: Irbesartan Zentiva sadrži laktozu.
English: CHINOIN PRIVATE CO. LTD.
Croatian: Chinoin Private Co.
English: Some undesirable effects have been reported since marketing of Irbesartan Zentiva.
Croatian: Neke nuspojave prijavljene su otkad je Irbesartan Zentiva na tržištu.
English: Warning and precautions Talk to your doctor before taking Irbesartan Zentiva and if any of the following apply to you: if you get excessive vomiting or diarrhoea if you suffer from kidney problems if you suffer from heart problems if you receive Irbesartan Zentiva for diabetic kidney disease.
Croatian: Obratite se svom liječniku prije nego uzmete Irbesartan Zentiva ako se nešto od dolje navedenog odnosi na Vas: ako Vas muči prekomjerno povraćanje ili proljev ako imate problema s bubrezima ako imate srčanih problema ako uzimate Irbesartan Zentiva zbog dijabetičke bolesti bubrega.
English: In patients insufficiently controlled with 150 mg once daily, the dose of Irbesartan Zentiva can be increased to 300 mg, or other antihypertensive agents can be added (see sections 4.3, 4.4, 4.5 and 5.1).
Croatian: U bolesnika u kojih se bolest ne može dostatno kontrolirati dozom od 150 mg jedanput na dan, doza lijeka Irbesartan Zentiva može se povećati na 300 mg ili se mogu dodati drugi antihipertenzivi (vidjeti dijelove 4.3, 4.4, 4.5 i 5.1).
English: Common (may affect up to 1 10 people): dizziness, feeling sick/vomiting, fatigue and blood tests may show raised levels of an enzyme that measures the muscle and heart function (creatine kinase enzyme).
Croatian: Često (mogu se javiti u manje od 1 na 10 osoba): omaglica, mučnina/povraćanje, umor, a krvne pretrage mogu pokazati povišenu razinu enzima specifičnog za mišićnu i srčanu funkciju (enzim kreatinin kinaza).
English: While similar blood pressure was achieved in all treatment groups, fewer subjects in the irbesartan 300 mg group (5.2%) than in the placebo (14.9%) or in the irbesartan 150 mg group (9.7%) reached the endpoint of overt proteinuria, demonstrating a 70% relative risk reduction versus placebo (p = 0.0004) for the higher dose.
Croatian: Dok je sličan krvni tlak postignut u svim ispitivanim skupinama, manje bolesnika u skupini koja je primala 300 mg irbesartana (5,2%) dostiglo je mjeru ishoda manifestne proteinurije u odnosu na skupinu koja je primala placebo (14,9%) ili na skupinu koja je primala 150 mg irbesartana (9,7%), pokazujući smanjenje relativnog rizika za 70% pri primjeni veće doze u odnosu na placebo (p=0,0004).
English: arthralgia, myalgia (in some cases associated with increased plasma creatine kinase levels), muscle cramps Renal and urinary disorders Not known:
Croatian: artralgija, mialgija (u nekim slučajevima povezana s povećanom koncentracijom kreatin kinaze u plazmi), grčevi mišića
English: hypersensitivity reactions such as angioedema, rash, urticaria, anaphylactic reaction,anaphylactic shock
Croatian: reakcije preosjetljivosti kao što su angioedem, osip, urtikarija, anafilaktička reakcija, anafilaktički šok Poremećaji metabolizma i prehrane Nepoznato:
English: At the end of the three weeks the mean reduction from baseline in the primary efficacy variable, trough seated systolic blood pressure (SeSBP) was 11.7 mmHg (low dose), 9.3 mmHg (medium dose), 13.2 mmHg (high dose).
Croatian: Nakon tri tjedna srednja vrijednost smanjenja krvnog tlaka u odnosu na početne vrijednosti za primarnu varijablu djelotvornosti, sistolički krvni tlak u sjedećem položaju kod najniže koncentracije u krvi (SjSKT), iznosila je 11,7 mmHg (niska doza), 9,3 mmHg (srednja doza) i 13,2 mmHg (visoka doza).
English: Irbesartan Zentiva is for oral use.
Croatian: Irbesartan Zentiva je namijenjen za primjenu kroz usta.
English: The demonstration of renal benefit of Irbesartan Zentiva in hypertensive type 2 diabetic patients is based on studies where irbesartan was used in addition to other antihypertensive agents, as needed, to reach target blood pressure (see sections 4.3, 4.4, 4.5 and 5.1).
Croatian: Dokaz koristi lijeka Irbesartan Zentiva na bubrežnu funkciju u hipertenzivnih bolesnika sa šećernom bolešću tipa 2 zasniva se na ispitivanjima u kojima se irbesartan prema potrebi uzimao kao dopuna ostaloj antihipertenzivnoj terapiji za postizanje ciljnog krvnog tlaka (vidjeti dijelove 4.3, 4.4, 4.5 i
English: How to store Irbesartan Zentiva
Croatian: Kako čuvati Irbesartan Zentiva
English: Irbesartan Zentiva slows the decrease of kidney function in patients with high blood pressure and type 2 diabetes.
Croatian: Irbesartan Zentiva usporava slabljenje bubrežne funkcije u bolesnika koji imaju povišen krvni tlak i boluju od šećerne bolesti tipa 2.
English: General: in patients whose vascular tone and renal function depend predominantly on the activity of the renin-angiotensin-aldosterone system (e.g. patients with severe congestive heart failure or underlying renal disease, including renal artery stenosis), treatment with angiotensin converting enzyme inhibitors or angiotensin-II receptor antagonists that affect this system has been associated with acute hypotension, azotaemia, oliguria, or rarely acute renal failure (see section 4.5).
Croatian: Općenito: u bolesnika u kojih vaskularni tonus i funkcija bubrega ovise najviše o aktivnosti reninangiotenzin-aldosteronskog sustava (npr. bolesnici s teškim kongestivnim zatajenjem srca ili postojećom bolešću bubrega, uključujući stenozu bubrežne arterije) liječenje inhibitorima angiotenzin konvertirajućeg enzima ili antagonistima receptora angiotenzina II, koji utječu na taj sustav, povezano je s pojavom akutne hipotenzije, azotemije, oligurije i rijetko, akutnim zatajenjem bubrega (vidjeti dio 4.5).
English: Diabetes Mellitus (IRMA 2)” shows that irbesartan 300 mg delays progression to overt proteinuria in patients with microalbuminuria.
Croatian: Kliničko ispitivanje „Učinak irbesartana na mikroalbuminuriju u hipertenzivnih bolesnika sa šećernom bolešću tipa 2 (IRMA 2)“ pokazuje da 300 mg irbesartana odgađa progresiju do izražene proteinurije u bolesnika s mikroalbuminurijom.
English: The concomitant use of Irbesartan Zentiva with aliskiren-containing products is contraindicated in patients with diabetes mellitus or renal impairment (glomerular filtration rate (GFR) <60 ml/min/1.73m2) (see sections 4.5 and 5.1).
Croatian: Istodobna primjena lijeka Irbesartan Zentiva s lijekovima koji sadrže aliskiren kontraindicirana je u bolesnika sa šećernom bolešću ili oštećenjem bubrega (GFR < 60 ml/min/1,73 m2) (vidjeti dijelove 4.5 i 5.1).
English: How to store Irbesartan Zentiva Contents of the pack and other information
Croatian: Kako Irbesartan Zentiva izgleda i sadržaj pakiranja
English: Irbesartan Zentiva is not recommended in early pregnancy, and must not be taken if you are more than 3 months pregnant, as it may cause serious harm to your baby if used at that stage (see pregnancy section).
Croatian: Ne smijete ga uzimati nakon trećeg mjeseca trudnoće jer može ozbiljno naškoditi Vašem djetetu ako ga uzimate u tom stadiju (vidjeti dio o trudnoći).
English: Each tablet of Irbesartan Zentiva 75 mg contains 75 mg irbesartan.
Croatian: Jedna Irbesartan Zentiva 75 mg tableta sadrži 75 mg irbesartana.
English: Marketing Authorisation Holder: Zentiva k.s.
Croatian: Nositelj odobrenja za stavljanje lijeka u promet: Zentiva k.s.
English: Each tablet of Irbesartan Zentiva 300 mg contains 300 mg irbesartan.
Croatian: Jedna Irbesartan Zentiva 300 mg tableta sadrži 300 mg irbesartana.
English: Each tablet of Irbesartan Zentiva 150 mg contains 150 mg irbesartan.
Croatian: Jedna Irbesartan Zentiva 150 mg tableta sadrži 150 mg irbesartana.
English: In this case your doctor may perform regular blood tests, especially for measuring blood potassium levels in case of poor kidney function if you are going to have an operation (surgery) or be given anaesthetics if you are taking any of the following medicines used to treat high blood pressure:
Croatian: U tom će Vam slučaju Vaš liječnik možda raditi redovite pretrage krvi, posebno određivanje koncentracije kalija u krvi u slučaju oslabljene funkcije bubrega ako trebate ići na bilo kakav kirurški zahvat ili trebate primiti anestetike ako uzimate bilo koji od lijekova navedenih u nastavku, koji se koriste za liječenje visokog krvnog tlaka: ACE inhibitor (primjerice enalapril, lisinopril, ramipril), osobito ako imate bubrežne tegobe povezane sa šećernom bolešću. aliskiren Liječnik Vam može provjeravati bubrežnu funkciju, krvni tlak i količinu elektrolita (npr. kalija) u krvi u redovitim intervalima.
English: Diuretics and other antihypertensive agents: other antihypertensive agents may increase the hypotensive effects of irbesartan; however Irbesartan Zentiva has been safely administered with other antihypertensive agents, such as beta-blockers, long-acting calcium channel blockers, and thiazide diuretics.
Croatian: Irbesartan Zentiva se, međutim, pokazao sigurnim za primjenu s ostalim antihipertenzivnim lijekovima poput beta blokatora, dugodjelujućih blokatora kalcijevih kanala i tiazida.
English: NAME OF THE MEDICINAL PRODUCT Irbesartan Zentiva 75 mg tablets irbesartan STATEMENT OF ACTIVE SUBSTANCE(S) Each tablet contains: irbesartan 75 mg LIST OF EXCIPIENTS Excipients: also contains lactose monohydrate.
Croatian: PODACI KOJI SE MORAJU NALAZITI NA VANJSKOM PAKIRANJU KUTIJA NAZIV LIJEKA Irbesartan Zentiva 75 mg tablete irbesartan NAVOĐENJE DJELATNE(IH) TVARI Jedna tableta sadrži 75 mg irbesartana POPIS POMOĆNIH TVARI Pomoćne tvari: također sadrži laktozu hidrat.
English: If you take more Irbesartan Zentiva than you should If you accidentally take too many tablets, contact your doctor immediately.
Croatian: Ako slučajno uzmete previše tableta, odmah se obratite svom liječniku.
English: The PSUR cycle of Irbesartan Zentiva is aligned with the cross-referred product, APROVEL, until otherwise specified.
Croatian: Podnošenje PSUR-a za lijek Irbesartan Zentiva trebalo bi pratiti raspored podnošenja PSUR-a za referentni lijek, APROVEL, do drugačije dogovorenog.
English: Irbesartan Zentiva 75 mg film-coated tablets irbesartan
Croatian: Irbesartan Zentiva 75 mg filmom obložene tablete irbesartan